Menu
GeneBe

X-124025683-A-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001042750.2(STAG2):c.45-157A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0338 in 111,558 control chromosomes in the GnomAD database, including 61 homozygotes. There are 1,133 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.034 ( 61 hom., 1133 hem., cov: 21)

Consequence

STAG2
NM_001042750.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0130
Variant links:
Genes affected
STAG2 (HGNC:11355): (STAG2 cohesin complex component) The protein encoded by this gene is a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Targeted inactivation of this gene results in chromatid cohesion defects and aneuploidy, suggesting that genetic disruption of cohesin is a cause of aneuploidy in human cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-124025683-A-G is Benign according to our data. Variant chrX-124025683-A-G is described in ClinVar as [Benign]. Clinvar id is 1230217.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0338 (3772/111558) while in subpopulation NFE AF= 0.0483 (2559/53012). AF 95% confidence interval is 0.0467. There are 61 homozygotes in gnomad4. There are 1133 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 61 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
STAG2NM_001042750.2 linkuse as main transcriptc.45-157A>G intron_variant ENST00000371145.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
STAG2ENST00000371145.8 linkuse as main transcriptc.45-157A>G intron_variant 1 NM_001042750.2 P1Q8N3U4-2

Frequencies

GnomAD3 genomes
AF:
0.0338
AC:
3773
AN:
111509
Hom.:
61
Cov.:
21
AF XY:
0.0337
AC XY:
1135
AN XY:
33709
show subpopulations
Gnomad AFR
AF:
0.0119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0256
Gnomad ASJ
AF:
0.0208
Gnomad EAS
AF:
0.000555
Gnomad SAS
AF:
0.0167
Gnomad FIN
AF:
0.0719
Gnomad MID
AF:
0.0294
Gnomad NFE
AF:
0.0483
Gnomad OTH
AF:
0.0294
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0338
AC:
3772
AN:
111558
Hom.:
61
Cov.:
21
AF XY:
0.0336
AC XY:
1133
AN XY:
33768
show subpopulations
Gnomad4 AFR
AF:
0.0119
Gnomad4 AMR
AF:
0.0256
Gnomad4 ASJ
AF:
0.0208
Gnomad4 EAS
AF:
0.000557
Gnomad4 SAS
AF:
0.0168
Gnomad4 FIN
AF:
0.0719
Gnomad4 NFE
AF:
0.0483
Gnomad4 OTH
AF:
0.0290
Alfa
AF:
0.0402
Hom.:
227
Bravo
AF:
0.0309

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMay 17, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
Cadd
Benign
0.77
Dann
Benign
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79769028; hg19: chrX-123159533; API